The economic implications of broader sharing of liver allografts

American Journal of Transplantation

Volumn 11, Issue 4, 2011, Pages 798-807

  Axelrod, D A ^a   Gheorghian, A ^b   Schnitzler, M A ^b   Dzebisashvili, N ^b   Salvalaggio, P R ^b   Tuttle Newhall, J ^b   Segev, D L ^c   Gentry, S ^d   Hohmann, S ^e   Merion, R M ^f   Lentine, K L ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNITED STATES NAVAL ACADEMY   (United States)

^e University HealthSystem Consortium ^*  (United States)

^f UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cost effectiveness; healthcare costs; liver transplantation; model for end stage liver disease; organ allocation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; END STAGE LIVER DISEASE; FEMALE; HOSPITAL COST; HUMAN; LIVER GRAFT; MALE; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SIMULATION;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; COSTS AND COST ANALYSIS; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, ECONOMIC; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; YOUNG ADULT;

EID: 79953249747     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03443.x     Document Type: Article

References (33)

1. Washburn WK, Pollock BH, Nichols L, Speeg KV, Halff G,. Impact of recipient MELD score on resource utilization. Am J Transplant 2006; 6: 2449-2454. (Pubitemid 44359433)
2. Freeman RB Jr,. Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card. Hepatology 2008; 47: 1052-1057. (Pubitemid 351449696)
3. Trotter JF, Osgood MJ,. MELD scores of liver transplant recipients according to size of waiting list: Impact of organ allocation and patient outcomes. JAMA 2004; 291: 1871-1874. (Pubitemid 38509500)
4. Roberts JP, Dykstra DM, Goodrich NP, Rush SH, Merion RM, Port FK,. Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant 2006; 6: 2470-2475. (Pubitemid 44359436)
5. Axelrod D, Millman D, Abecassis MM,. U.S. health care reform and transplantation Part I: Overview and impact on access and reimbursement in the private sector. Am J Transplant, 2010; 10: 2197-2202.
6. Axelrod D, Millman D, Abecassis M,. U.S. health care reform and transplantation Part II: Impact on the public sector and novel healthcare delivery systems. Am J Transplant, 2010; 10: 2203-2207.
7. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA,. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313. (Pubitemid 40179517)
8. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM,. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008; 8: 419-425. (Pubitemid 351175358)
9. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM,. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990-997. (Pubitemid 46481202)
10. Salvalaggio PR, Dzebisashvili N, MacLeod KE, et al., The interaction among donor characteristics, severity of liver disease and the cost of liver transplantation. Liver Transpl 2010 (in press).
11. Axelrod DA, Koffron AJ, Baker T, et al,. The economic impact of MELD on liver transplant centers. Am J Transplant 2005; 5: 2297-2301. (Pubitemid 41648479)
12. Washburn WK, Meo NA, Halff GA, Roberts JP, Feng S,. Factors influencing liver transplant length of stay at two large-volume transplant centers. Liver Transpl 2009; 15: 1570-1578.
13. Jay CL, Lyuksemburg V, Kang R, et al, The increased costs of donation after cardiac death liver transplantation: Caveat emptor. Ann Surg 2010; 251: 743-748.
14. Geevarghese SK, Bradley AE, Wright JK, et al., Outcomes analysis in 100 liver transplantation patients. Am J Surg 1998; 175: 348-353. (Pubitemid 28213442)
15. Feng S, Goodrich NP, Bragg-Gresham JL, et al., Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790. (Pubitemid 43345017)
16. Bureau of Labor Statistics. Consumer Price Index, US Average Medical Care. Available at:. Accessed August 7, 2009.
17. Available at:. Accessed November 24, 2010.
18. Thompson D, Waisanen L, Wolfe R, Merion RM, McCullough K, Rodgers A,. Simulating the allocation of organs for transplantation. Health Care Manag Sci 2004; 7: 331-338. (Pubitemid 40386210)
19. Schnitzler MA, Whiting JF, Brennan DC, et al., The life-years saved by a deceased organ donor. Am J Transplant 2005; 5: 2289-2296. (Pubitemid 41648478)
20. Salvalaggio PR, Dzebisashvili N, Pinsky B, et al., Incremental value of the pancreas allograft to the survival of simultaneous pancreas-kidney transplant recipients. Diabetes Care 2009; 32: 600-602.
21. Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL,. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 1997; 127: 855-865.
22. Axelrod DA, Swindle J, Salvalaggio PR, Buchanan P, Schnitzler M,. Reducing the cost of marginal organ utilization: Is there a national learning curve? Am J Transplant 2007; 7: 283-284. Am J Transplant 2007; Suppl 7: 283- 284 (Abstr).
23. Merion RM, Pelletier SJ, Goodrich N, Englesbe MJ, Delmonico FL,. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006; 244: 555-562.
24. Skaro AI, Jay CL, Baker TB, et al., The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: The untold story. Surgery 2009; 146: 543-552; discussion 552-543.
25. de Vera ME, Lopez-Solis R, Dvorchik I, et al., Liver transplantation using donation after cardiac death donors: Long-term follow-up from a single center. Am J Transplant 2009; 9: 773-781.
26. Northup PG, Abecassis MM, Englesbe MJ, et al., Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009; 15: 148-162.
27. Chambers JD, Neumann PJ, Buxton MJ,. Does Medicare have an implicit cost-effectiveness threshold? Med Decis Making 2010; 30: E14-E27.
28. Cost Effectiveness Analysis Registry. Available at:. Accessed November 20, 2010.
29. Ubel PA, Hirth RA, Chernew ME, Fendrick AM,. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003; 163: 1637-1641. (Pubitemid 36898950)
30. Buchanan P, Dzebisashvili N, Lentine KL, Axelrod DA, Schnitzler MA, Salvalaggio PR,. Liver transplantation cost in the model for end-stage liver disease era: Looking beyond the transplant admission. Liver Transpl 2009; 15: 1270-1277.
31. Schoenberg IJ,. Contributions to the problem of approximation of equidistant data by analytic functions. Quart Appl Math 1946; 4: 45-99, and 112- 141.
32. Ruppert D, Wand MP, Carroll RJ,. Semiparametric regression. New York: Cambridge University Press; 2003.
33. Woodward RS, Schnitzler MA, Baty J, et al., Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 2003; 3: 590-598. (Pubitemid 36612842)